證據(jù)文獻(xiàn)
| NO | 論文 | 登載期刊 | PM ID | 全文鏈接 | 中文鏈接 |
|---|---|---|---|---|---|
| 1 | 輔助免疫細(xì)胞療法與全身系統(tǒng)性療法結(jié)合治療實(shí)體瘤的療效 | Anticancer Research 42: 4179-4187 / 2022 | 35896218 | https://ar.iiarjournals.org/content/42/8/4179 | http://www.sunny-funny.com/laitian/results/22.html |
| 2 | 食管癌對(duì)免疫細(xì)胞療法和低劑量納武單抗聯(lián)合治療有反應(yīng) | Journal of Medical Case Reports 15, Article number: 191 / 2021 | 33827668 | https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z | http://www.sunny-funny.com/laitian/results/23.html |
| 3 | 免疫細(xì)胞療法治療晚期/復(fù)發(fā)性乳腺癌的預(yù)后因素 | Anticancer Research 41:4133-4141 / 2021 | 34281884 | https://ar.iiarjournals.org/content/41/8/4133.long | http://www.sunny-funny.com/laitian/results/1.html |
| 4 | 過(guò)繼性T細(xì)胞免疫治療對(duì)晚期胰腺癌患者免疫學(xué)指標(biāo)及預(yù)后的影響 | CYTOTHERAPYFeb;23(2):137-145/2020 | 32907781 | https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6 | http://www.sunny-funny.com/laitian/results/2.html |
| 5 | 接受一線化療免疫治療的轉(zhuǎn)移性結(jié)直腸癌患者的免疫狀態(tài)變化 | Anticancer Research 40:4763-4771 / 2020 | 32727803 | https://ar.iiarjournals.org/content/40/8/4763.long | http://www.sunny-funny.com/laitian/results/3.html |
| 6 | 過(guò)繼免疫細(xì)胞治療子宮頸神經(jīng)內(nèi)分泌癌 | Anticancer Research 40:4741-4748 / 2020 | 32727800 | https://ar.iiarjournals.org/content/40/8/4763 | http://www.sunny-funny.com/laitian/results/4.html |
| 7 | 免疫細(xì)胞治療子宮內(nèi)膜癌和宮頸癌預(yù)后因素的回顧性研究 | Anticancer Research 40:4729-4740 / 2020 | 32727799 | https://ar.iiarjournals.org/content/40/8/4729.long | http://www.sunny-funny.com/laitian/results/5.html |
| 8 | 適應(yīng)性免疫細(xì)胞治療對(duì)晚期胃癌患者免疫細(xì)胞譜的影響 | Cancer Med 9(14):4907-4917 / 2020 | 32529780 | https://ar.iiarjournals.org/content/40/8/4729.long | http://www.sunny-funny.com/laitian/results/6.html |
| 9 | γδT細(xì)胞免疫治療實(shí)體瘤預(yù)后因素的研究 | CYTOTHERAPY Jun;22(6):329-336 / 2020 | 32303429 | https://pubmed.ncbi.nlm.nih.gov/32303429/ | http://www.sunny-funny.com/laitian/results/7.html |
| 10 | 免疫細(xì)胞聯(lián)合一線化療治療結(jié)直腸癌的預(yù)后因素：一項(xiàng)回顧性研究 | Anticancer Research 39: 4525-4532 / 2019 | 31366555 | https://pubmed.ncbi.nlm.nih.gov/31366555/ | http://www.sunny-funny.com/laitian/results/8.html |
| 11 | 免疫細(xì)胞治療胰腺癌患者的預(yù)后因素 | Anticancer Research 38 (7) 4353-4360 / 2018 | 29970573 | https://pubmed.ncbi.nlm.nih.gov/29970573/ | http://www.sunny-funny.com/laitian/results/9.html |
| 12 | 腫瘤內(nèi)注射唑來(lái)膦酸鹽沖擊樹(shù)突狀細(xì)胞、靜脈過(guò)繼活化T淋巴細(xì)胞和吉西他濱聯(lián)合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究 | Oncotarget Dec5;9(2):2838-2847./2017 | 29416816 | https://pubmed.ncbi.nlm.nih.gov/29416816/ | http://www.sunny-funny.com/laitian/results/10.html |
| 13 | 全身靜脈過(guò)繼轉(zhuǎn)移自體淋巴因子激活的αβT細(xì)胞改善替莫唑胺誘導(dǎo)的膠質(zhì)瘤患者淋巴細(xì)胞減少 | Anticancer Research Jul;37(7):3921-3932./2017 | 28668896 | https://pubmed.ncbi.nlm.nih.gov/28668896/ | http://www.sunny-funny.com/laitian/results/11.html |
| 14 | 過(guò)繼免疫聯(lián)合化療治療IV期結(jié)直腸癌的臨床研究（COMVI研究） | Anticancer Research Jul;37(7):3941-3946. / 2017 | 28668898 | https://pubmed.ncbi.nlm.nih.gov/28668898/ | http://www.sunny-funny.com/laitian/results/12.html |
| 15 | 過(guò)繼免疫細(xì)胞療法治療晚期胃癌的回顧性研究 | Anticancer Research Jul;37(7):3947-3954. / 2017 | 28668899 | https://pubmed.ncbi.nlm.nih.gov/28668899/ | http://www.sunny-funny.com/laitian/results/13.html |
| 16 | mRNA-EP制備的腫瘤血管靶向CAR-T細(xì)胞用于臨床研究的免疫學(xué)質(zhì)量和性能 | Mol Ther Oncolytics.Nov 16;3:16024. / 2016 | 27909701 | https://pubmed.ncbi.nlm.nih.gov/27909701/ | http://www.sunny-funny.com/laitian/results/14.html |
| 17 | 活化αβT細(xì)胞過(guò)繼免疫化療治療IV期結(jié)直腸癌 | Anticancer Research Jul;36(7):3741-6. / 2016 | 27354648 | https://pubmed.ncbi.nlm.nih.gov/27354648/ | http://www.sunny-funny.com/laitian/results/15.html |
| 18 | WT1抗原在多種實(shí)體癌細(xì)胞中表達(dá)的免疫組織化學(xué)分析 | Anticancer Research 36(7):3715-3724 / 2016 | 27354645 | https://pubmed.ncbi.nlm.nih.gov/27354645/ | http://www.sunny-funny.com/laitian/results/16.html |
| 19 | 自體免疫細(xì)胞治療改善不同類型晚期癌癥患者的免疫功能受損 | Anticancer Research 36(7):3715-3724 / 2016 | 26168498 | https://pubmed.ncbi.nlm.nih.gov/26168498/ | http://www.sunny-funny.com/laitian/results/17.html |
| 20 | 免疫細(xì)胞治療在不同類型晚期癌癥患者中的前瞻性安全性評(píng)價(jià) | Anticancer Research 35(8):4535-4543 / 2015 | 25075106 | https://pubmed.ncbi.nlm.nih.gov/25075106/ | http://www.sunny-funny.com/laitian/results/18.html |
| 21 | 在晚期癌癥患者中評(píng)估細(xì)胞免疫狀態(tài)受損和失衡，并通過(guò)過(guò)繼性T細(xì)胞免疫治療恢復(fù)T細(xì)胞免疫狀態(tài) | International Immunopharmacology18(1):90-97. / 2014 | 24269583 | https://pubmed.ncbi.nlm.nih.gov/24269583/ | http://www.sunny-funny.com/laitian/results/19.html |
| 22 | 封閉流式電穿孔系統(tǒng)治療實(shí)體瘤的自體腫瘤溶解物樹(shù)突狀細(xì)胞疫苗免疫治療 | Anticancer Research 33(7):2971-6. / 2013 | 23780988 | https://pubmed.ncbi.nlm.nih.gov/23780988/ | http://www.sunny-funny.com/laitian/results/20.html |
| 23 | 晚期肺癌過(guò)繼性活化T淋巴細(xì)胞免疫治療中觀察到的生存期延長(zhǎng)：一項(xiàng)多中心歷史性隊(duì)列研究的結(jié)果 | Cancer Immunology, Immunotherapy 61:1781-1790. / 2012 | 22422103 | https://pubmed.ncbi.nlm.nih.gov/22422103/ | http://www.sunny-funny.com/laitian/results/21.html |